Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 22, 2010

Premium

Personalized medicine company TcLand Expression announced the appointment of Peter Payne as its chief business officer, as well as the head of its US Operations.

Before joining TcLand Expressions, Payne worked for Quintiles Transnational Corp where he held various positions managing senior operations and business development in Europe and the US. Most recently, he was VP of corporate development at Quintiles responsible for inking strategic relationships with drug firms, venture capital funds, and other financial institutions.

TcLand Expression is developing personalized medicine companion diagnostics in immune mediated disorders and is clinically validating personalized medicine biomarkers for tolerance in liver transplantation.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.